Filing Details
- Accession Number:
- 0000899243-22-014110
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-04-06 16:39:27
- Reporting Period:
- 2022-04-04
- Accepted Time:
- 2022-04-06 16:39:27
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1527599 | Synlogic Inc. | SYBX | Pharmaceutical Preparations (2834) | 261824804 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1714563 | Aoife Brennan | C/O Synlogic, Inc. 301 Binney Street, Suite 402 Cambridge MA 02142 | See Remarks | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2022-04-04 | 8,894 | $2.45 | 275,343 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Represents the number of shares sold by the reporting person on April 4, 2022 to cover the tax liability in connection with the vesting of two restricted stock awards, vesting on April 1, 2022, that were granted in 2020 and 2021. The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 26, 2021.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.40 to $2.45, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
Billionaire Hedge Funds
